Nov 11 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 71.30 77.34 150.50
(-7.8 pct) (+15.0 pct) (-9.9 pct)
Operating 6.47 7.17 13.10
(-9.9 pct) (+38.0 pct) (-16.5 pct)
Recurring 6.82 7.51 13.40
(-9.1 pct) (+33.4 pct) (-12.6 pct)
Net 4.19 4.87 7.50
(-14.0 pct) (+36.2 pct) (-17.6 pct)
EPS 36.83 yen 42.88 yen 65.88 yen
EPS Diluted 36.68 yen 42.70 yen
Ann Div 20.00 yen 21.00 yen
-Q2 div 10.00 yen 10.00 yen
-Q4 div 10.00 yen 11.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T
((Tokyo Headline News Desk +813 6441 1812))